More than 100 advocacy groups supporting abortion rights are urging the House to remove a controversial provision from the GOP bill that aims to fund the FDA. Concerns have been raised surrounding the provision in the spending bill, which seeks to impose stricter restrictions on mifepristone, an abortion pill. Specifically, the provision would overturn the FDA’s decision to permit mail delivery and retail sale of the drug. The groups, led by Planned Parenthood Federation of America and Physicians for Reproductive Health, argue that this provision infringes on individuals’ freedom to make decisions about their own bodies and view it as an unwarranted addition to the annual appropriations bills. Originally planned for a vote on Thursday, House GOP leaders have faced opposition from moderates who oppose the abortion language, as well as hard-line conservatives who demand significant spending cuts. Consequently, the vote on the bill is likely to be delayed until September. The groups have expressed support for a proposed amendment by Rep. Rosa DeLauro (D-Conn.) to remove the provision from the bill; however, it remains uncertain whether this amendment will receive a vote. This bill is one instance of House Republicans attempting to advance anti-abortion measures and conservative health priorities through must-pass spending bills. By including anti-abortion measures in nearly every appropriation bill, Republicans complicate negotiations with the Senate and risk a government shutdown.
Denial of responsibility! VigourTimes is an automatic aggregator of Global media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, and all materials to their authors. For any complaint, please reach us at – [email protected]. We will take necessary action within 24 hours.
